December 5, 2014
Total offer size of IPO reaches CHF 106.2 million after partial exercise of IPO over-allotment option

 
December 4, 2014
PneumRx Acquired by BTG plc for up to USD 475 Million

 
November 6, 2014
BIND Therapeutics Announces Agreement with Merck to Develop Targeted Accurin™ Nanomedicines for Oncology

 
November 6, 2014
Molecular Partners has successfully priced its IPO post re-launch and lists its shares on SIX Swiss Exchange

 
September 23, 2014
Molecular Partners launches IPO on SIX Swiss Exchange

 
more...
© Endeavour Vision SA 2006-2014 Terms & Conditions